Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal baclofen treatment in dystonic cerebral palsy
2010-019768-35Phase 3Active
- Start
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of baclofen in dystonic cerebral palsy (2 arms). Primary endpoint: Goal Attainment Scaling (GAS). Started Jan 2013; status: active.
02
Drugs
baclofen
03
Conditions
dystonic cerebral palsy
Beyond the preview
Go deeper on 2010-019768-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019768-35.